Fatty Acid Desaturase 1 Human Recombinant

SAN DIEGO - July 29, 2024 - PRLog -- Fatty Acid Desaturase 1 Human Recombinant

Fatty Acid Desaturase 1 (FADS1) is an enzyme that plays a key role in the biosynthesis of long-chain polyunsaturated fatty acids (PUFAs) in humans. It is involved in the desaturation of fatty acids, converting saturated fatty acids into unsaturated fatty acids. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.

Fatty Acid Desaturase 1 Human Recombinant
Catalog number: B2017434
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 300 µg
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: −20°C
Keywords: Acyl-CoA (8-3)-Desaturase, FADS1, Δ5 Fatty Acid Desaturase
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Aragón-Herrera A, Feijóo-Bandín S, Abella V, Álvarez L, Roselló-Lletí E, Portolés M, Tarazón E, Bigazzi M, Bani D, Gualillo O, González-Juanatey JR, Lago F. Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue Pharmacol Res. 2019 Jun;144:51-65.
2: Aragón-Herrera A, Feijóo-Bandín S, Moraña-Fernández S, Anido-Varela L, Roselló-Lletí E, Portolés M, Tarazón E, Lage R, Moscoso I, Barral L, Bani D, Bigazzi M, Gualillo O, González-Juanatey JR, Lago F. Relaxin has beneficial effects on liver lipidome and metabolic enzymes FASEB J. 2021 Jul;35(7):e21737.

https://moleculardepot.com/product/fatty-acid-desaturase-...